Center for Cardiac Arrest Prevention, Smidt Heart Institute, Cedars-Sinai Health System, Los Angeles, California.
Knight Cardiovascular Institute, Oregon Health and Science University, Portland, Oregon.
Heart Rhythm. 2021 May;18(5):778-784. doi: 10.1016/j.hrthm.2020.12.035. Epub 2021 Jan 20.
In the absence of apparent triggers, sudden cardiac death (SCD) during nighttime hours is a perplexing and devastating phenomenon. There are few published reports in the general population, with insufficient numbers to perform sex-specific analyses. Smaller studies of rare nocturnal SCD syndromes suggest a male predominance and implicate sleep-disordered breathing.
The purpose of this study was to identify mechanisms of nighttime SCD in the general population.
From the population-based Oregon Sudden Unexpected Death Study, we evaluated SCD cases that occurred in the community between 10 PM and 6 AM (nighttime) and compared them with daytime cases. Univariate comparisons were evaluated using Pearson χ tests and independent samples t tests. Logistic regression was used to further assess independent SCD risk.
A total of 4126 SCD cases (66.2% male, 33.8% female) met criteria for analysis and 22.3% (n = 918) occurred during nighttime hours. Women were more likely to present with nighttime SCD than men (25.4% vs 20.6%; P < .001). In a multivariate regression model, female sex (odds ratio [OR] 1.3 [confidence interval (CI) 1.1-1.5]; P = .001), medications associated with somnolence/respiratory depression (OR 1.2 [CI 1.1-1.4]; P = .008) and chronic obstructive pulmonary disease/asthma (OR 1.4 [CI 1.1-1.6]; P < .001) were independently associated with nighttime SCD. Women were taking more central nervous system-affecting medications than men (1.9 ± 1.7 vs 1.4 ± 1.4; P = .001).
In the general population, women were more likely than men to suffer SCD during nighttime hours and female sex was an independent predictor of nighttime events. Respiratory suppression is a concern, and caution is advisable when prescribing central nervous system-affecting medications to patients at an increased risk of SCD, especially women.
在没有明显诱因的情况下,夜间发生的心脏性猝死(SCD)是一种令人费解且具有毁灭性的现象。普通人群中仅有少数相关报道,且病例数不足以进行性别特异性分析。对罕见夜间 SCD 综合征的较小研究表明,男性居多,并提示与睡眠呼吸障碍有关。
本研究旨在确定普通人群中夜间 SCD 的发生机制。
我们对在社区中于晚上 10 点至早上 6 点(夜间)发生的心脏性猝死病例进行了一项基于人群的俄勒冈州意外猝死研究,并将其与白天发生的病例进行了比较。采用 Pearson χ检验和独立样本 t 检验进行单变量比较。采用 logistic 回归进一步评估独立的 SCD 风险。
共有 4126 例 SCD 病例(66.2%为男性,33.8%为女性)符合分析标准,其中 22.3%(n=918)发生在夜间。与男性相比,女性更有可能发生夜间 SCD(25.4%比 20.6%;P<.001)。在多变量回归模型中,女性(比值比[OR]1.3[95%置信区间(CI)1.1-1.5];P=.001)、与嗜睡/呼吸抑制相关的药物(OR 1.2[95%CI 1.1-1.4];P=.008)和慢性阻塞性肺疾病/哮喘(OR 1.4[95%CI 1.1-1.6];P<.001)是与夜间 SCD 独立相关的因素。与男性相比,女性服用的影响中枢神经系统的药物更多(1.9±1.7 比 1.4±1.4;P=.001)。
在普通人群中,女性夜间发生 SCD 的可能性高于男性,女性是夜间事件的独立预测因素。呼吸抑制是一个关注点,在为 SCD 风险增加的患者开具影响中枢神经系统的药物时应谨慎,尤其是女性。